| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |